Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Dipeptide-2 | Dipeptide-2 is a synthetic peptide used for skin care. It can inhibit angiotensin converting enzyme ACE, enhance the lymphatic circulation of the eye, promote water discharge, and effectively eliminate edema and reduce eye bags. Uses: dipeptide-2 is a compound composed of valine and tryptophan. in general, peptides are short chains of amino acids that can function as signaling molecules, influencing a variety of physiological processes. dipeptide-2 has been specifically implicated in enhancing lymphatic circulation and reducing inflammation, making it particularly effective in cosmetic formulations designed to reduce puffine. Group: Pharmaceutical. CAS No. 24587-37-9. Pack Sizes: 1 g. Product ID: BAT-010786. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Dipeptide diaminobutyroyl benzylamide diacetate | Dipeptide diaminobutyroyl benzylamide is a biomimetic peptide and a muscarinic acetylcholine receptor antagonist. It mimics the action of the temple viper venom peptide Waglerin-1 to block sodium uptake and induce muscle relaxation. A cosmetic formulation acts as an anti-wrinkle ingredient used in anti-aging products. Group: Pharmaceutical. CAS No. 823202-99-9. Pack Sizes: 1 g. Product ID: BAT-010789. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palmitoyl Dipeptide-7 | Palmitoyl Dipeptide-7. Group: Pharmaceutical. CAS No. 911813-90-6. Pack Sizes: 5 mg. Product ID: BAT-006231. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Alaptide Impurities | Alaptide Impurities hold substantial significance within the pharmaceutical domain, particularly in quality assurance during Alaptide synthesis, a dipeptide salient for its wound healing and anti-inflammatory prospects. They provide critical insights into Alaptide's efficacy and safety, optimizing therapeutic applications in dermatological scenarios, thereby ensuring comprehensive treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclo(L-Leu-L-Pro) | Cyclo (-Leu-Pro) is a cyclic dipeptide containing leucine and proline. Group: Pharmaceutical. CAS No. 2873-36-1. Pack Sizes: 1 g. Product ID: BAT-010167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| JE-2147 | JE-2147 is a dipeptide HIV protease inhibitor (PI) that is effective against a wide spectrum of HIV-1, HIV-2, simian immunodeficiency virus, and various clinical HIV-1 strains in vitro. Group: Pharmaceutical. CAS No. 186538-00-1. Pack Sizes: 10 mg. Product ID: B2693-008706. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-α-Aspartyl-D-phenylalanine methyl ester | L-α-Aspartyl-D-phenylalanine methyl ester, a dipeptide compound, bears promise in the biomedical sector for its potential inhibitory impact on angiotensin converting enzyme (ACE), thus potentially reducing blood pressure levels. It has also shown potential in the treatment of hypertensive, cardiac failure, and other cardiovascular conditions. The study of its properties continues to generate interest and attention from academia and the scientific community. Group: Pharmaceutical. CAS No. 22839-65-2. Pack Sizes: 50 mg. Product ID: B2699-116576. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Carnosine | L-Carnosine is a dipeptide concentrated in muscle and brain tissue. It acts as an antioxidant that scavenges reactive oxygen species (ROS) and transition metal ions. It is also a neurotransmitter in the brain. L-Carnosine has potential antioxidant and anti-glycosylation activities, preventing acetaldehyde-induced non-enzymatic glycosylation and protein coupling. It is also a substrate for carnosinase detection, which can maintain pH balance in the body and extend cell life. Group: Pharmaceutical. CAS No. 305-84-0. Pack Sizes: 100 g. Product ID: BAT-008152. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Acetyl Carnosine | N-Acetyl Carnosine is a naturally-occurring dipeptide used in the treatment of cataracts and in the treatment of UV-induced immunosuppression. Group: Pharmaceutical. CAS No. 56353-15-2. Pack Sizes: 1 g. Product ID: BAT-006160. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-L-γ-glutamyl-L-tyrosine | N-L-γ-glutamyl-L-tyrosine is a dipeptide produced by the catabolism of proteins. Group: Pharmaceutical. CAS No. 7432-23-7. Pack Sizes: 1 g. Product ID: BAT-015508. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pidotimod | Pidotimod is a synthetic dipeptide molecule with biological and immunological activity on both the adaptive and the innate immune responses. Group: Pharmaceutical. CAS No. 121808-62-6. Pack Sizes: 25 g. Product ID: NP3482. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Talabostat mesylate | Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines. Uses: For research used only. Group: Pharmaceutical. CAS No. 150080-09-4. Pack Sizes: 20 mg. Product ID: B0084-084554. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 1,1-Dimethylethyl N-[(3R)-1-[(2-cyanophenyl)methyl]-3-piperidinyl]carbamate | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 1353254-15-5. Pack Sizes: 100 mg. Product ID: B1370-425896. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2-[[3, 4-Dihydro-3-methyl-2, 4-dioxo-6-[ (3R)-3-piperidinylamino]-1 (2H)-pyrimidinyl]methyl]benzonitrile | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 2089611-85-6. Pack Sizes: 100 mg. Product ID: B1370-425895. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2'R,2S,cis)-Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 1564265-93-5. Pack Sizes: 2.5 mg. Product ID: B0016-007240. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2R)-Vildagliptin | (2R)-Vildagliptin is an R-enantiomer of Vildagliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an anti-hyperglycemic agent and an anti-diabetic drug. Group: Pharmaceutical. CAS No. 1036959-27-9. Pack Sizes: 20 mg. Product ID: B0020-461928. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Deoxy Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 361441-98-7. Pack Sizes: 2.5 mg. Product ID: B0016-007241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 4-((2-Hydroxyethoxy)carbonyl)benzoic acid | 4-((2-Hydroxyethoxy)carbonyl)benzoic acid, an essential pharmaceutical intermediate widely utilized for synthesizing dipeptidyl peptidase-4 (DPP-4) inhibitors, possesses potential anti-cancer properties with its pronounced efficacy in chronic myeloid leukemia (CML) and other cancer treatments. Plausible and encouraging observations in cancer research elucidate its immense promise as a therapeutic agent. Group: Pharmaceutical. CAS No. 1137-99-1. Pack Sizes: 100 mg. Product ID: B2699-223434. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acetyl 1-L-leucyL-L-arginine | Acetyl 1-L-leucyL-L-arginine is a lactone compound isolated from the Bacterium sp. BMG520-yF2. Acetyl 1-L-leucyL-L-arginine has the activity of inhibiting dipeptidyl aminopeptidase ?. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00009. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-Saxagliptin | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 709031-43-6. Pack Sizes: 25 mg. Product ID: B1370-149516. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cilastatin Ammonium Salt | Cilastatin Ammonium Salt is the ammonium salt of Cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Group: Pharmaceutical. CAS No. 877674-82-3. Pack Sizes: 500 mg. Product ID: B2693-468925. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cilastatin sodium | Cilastatin sodium is the sodium salt of cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Group: Pharmaceutical. CAS No. 81129-83-1. Pack Sizes: 1 g. Product ID: B0084-077802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cysteinyl-3M3SH | Cysteinyl-3M3SH is an intermediate in the bacterial biotransformation of the odourless physiological malodour precursor Cys-Gly-3M3SH. Cys-Gly-3M3SH is actively transported by the di-/tri-peptide transporter (DtpT) along with the movement of protons. Once inside the cell the terminal glycine is cleaved by a dipeptidase (PepA) to release Cys-3M3SH. Group: Pharmaceutical. Pack Sizes: 250 mg. Product ID: BAT-014377. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Diprotin A | It is produced by the strain of Bacillus cereus BMF 657-RF1. It can inhibit Dipeptidyl amino peptidase IV and immune enhancement effect. Group: Pharmaceutical. CAS No. 90614-48-5. Pack Sizes: 500 mg. Product ID: BAT-010802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Dha-OH | Fmoc-Dha-OH, a pivotal intermediate, is used for synthesizing a plethora of biologically active compounds encompassing antimicrobial peptides, dipeptidyl peptidase IV inhibitors, and enzyme inhibitors. Researchers have employed it to fabricate Fmoc-Dha-OH-derived peptidomimetics manifested by the impeding activity against a myriad of cancer cell lines. The said compound holds sheer potential for the design and development of novel pharmaceutical agents targeting numerous diseases. Group: Pharmaceutical. CAS No. 261522-33-2. Pack Sizes: 500 mg. Product ID: BAT-008269. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H-Gly-Pro-Hyp-OH | A peptide inhibitor of dipeptidylpeptidase-IV (DPP-IV). Group: Pharmaceutical. CAS No. 2239-67-0. Pack Sizes: 500 mg. Product ID: BAT-015714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Uses: The treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-12-0. Pack Sizes: 2.5 g. Product ID: NP2669. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurities | Linagliptin Impurities hold a paramount position in the biomedical sector, instrumental for pharmaceutical research and quality control paradigms. These impurities facilitate the synthesis and evaluation of linagliptin, a pivotal type 2 diabetes treatment via dipeptidyl peptidase-4 enzyme inhibition, thereby assuring the drug's purity and therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-11-9. Pack Sizes: 50 mg. Product ID: B0012-473823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 7 Hydrochloride | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 50 mg. Product ID: B1370-449757. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 2138392-83-1. Pack Sizes: 10 mg. Product ID: B2694-473825. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1446263-38-2. Pack Sizes: 10 mg. Product ID: B2694-242668. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1418133-47-7. Pack Sizes: 10 mg. Product ID: B2694-473827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Acetyl Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803079-49-3. Pack Sizes: 50 mg. Product ID: B0012-007233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 668273-75-4. Pack Sizes: 50 mg. Product ID: B0012-007234. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-acetic acid-1-amino-3-adamantanol | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1032564-18-3. Pack Sizes: 500 mg. Product ID: B2694-485169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Acetyl Sitagliptin | N-Acetyl Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1379666-94-0. Pack Sizes: 50 mg. Product ID: B2694-479646. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Cyano-N'-methyl-ethanimidamide | N-Cyano-N'-methyl-ethanimidamide has exhibited significant inhibitory activity against the dipeptidyl peptidase IV (DPP-4), which represents a pharmacological target for mitigating type 2 diabetes. In addition to this, the product has demonstrated antiviral potential against a diverse range of viral strains, among which the human immunodeficiency virus (HIV) is notable. The product's diverse clinical applications thus mandate in-depth investigation and analysis. Group: Pharmaceutical. CAS No. 56563-12-3. Pack Sizes: 5 g. Product ID: B1370-015289. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omarigliptin | Omarigliptin is a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor to be used as the treatment for type 2 diabetes. Group: Pharmaceutical. CAS No. 1226781-44-7. Pack Sizes: 25 mg. Product ID: B0084-462292. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PMPA sodium salt | PMPA is an inhibitor of glutamate carboxypeptidase 2 (GCP II/N-acetylated a-linked dipeptidase/NAALADase). Group: Pharmaceutical. CAS No. 373645-42-2. Pack Sizes: 50 mg. Product ID: B2693-342069. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide | (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide is an impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 1820685-30-0. Pack Sizes: 100 mg. Product ID: B1370-377540. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Sitagliptin | Rac-Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. CAS No. 823817-56-7. Pack Sizes: 50 mg. Product ID: B2693-211737. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Vildagliptin Impurity F | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1789703-36-1. Pack Sizes: 10 mg. Product ID: B2694-485167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Cyclic Amidine Impurity | An impurity of saxagliptin.Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Group: Pharmaceutical. CAS No. 1350800-76-8. Pack Sizes: 5 mg. Product ID: B0016-479455. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Impurity 15 | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 1496712-39-0. Pack Sizes: 2.5 mg. Product ID: B0016-479445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Impurity 7 | An impurity of saxagliptin.Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Group: Pharmaceutical. CAS No. 1350800-77-9. Pack Sizes: 2.5 mg. Product ID: B0016-479457. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Keto Impurity | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 2.5 mg. Product ID: B0016-007239. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity A Phosphate | Sitagliptin EP Impurity A Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 823817-58-9. Pack Sizes: 100 mg. Product ID: B0017-479659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B | Sitagliptin EP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 486460-31-5. Pack Sizes: 25 mg. Product ID: B2694-479656. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B Phosphate | Sitagliptin EP Impurity B Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1345822-87-8. Pack Sizes: 10 mg. Product ID: B2694-179047. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity C | Sitagliptin EP Impurity C is a impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 945261-48-3. Pack Sizes: 100 mg. Product ID: B2694-352408. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity C Phosphate | Sitagliptin EP Impurity C Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1345822-86-7. Pack Sizes: 30 mg. Product ID: B2694-174790. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin FP Impurity B | Sitagliptin FP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2088771-61-1. Pack Sizes: 5 mg. Product ID: B2694-334170. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin FP Impurity E Hydrochloride | Sitagliptin EP Impurity E is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1204818-19-8. Pack Sizes: 1 g. Product ID: BAT-008056. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Fumarate Adduct (Mixture of Diastereomers) | Sitagliptin Fumarate Adduct is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2088771-60-0. Pack Sizes: 50 mg. Product ID: B2694-032361. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Impurity 40 HCl | Sitagliptin Impurity 40 HCl is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1374985-05-3. Pack Sizes: 500 mg. Product ID: B2694-186710. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin phenylcrotonyl analog | Sitagliptin phenylcrotonyl analog is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1253056-18-6. Pack Sizes: 10 mg. Product ID: B0017-479654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Phosphate Monohydrate | Sitagliptin Phosphate Monohydrate is the phosphate salt form of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 654671-77-9. Pack Sizes: 100 g. Product ID: B2692-335254. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin styrylacetyl analog | Sitagliptin styrylacetyl analog is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803026-58-5. Pack Sizes: 10 mg. Product ID: B0017-004064. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (S)-Sitagliptin N-Boc-Acid Impurity | (S)-Sitagliptin N-Boc-Acid Impurity is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 922178-94-7. Pack Sizes: 1 g. Product ID: BAT-008080. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Teneligliptin | Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro. Group: Pharmaceutical. CAS No. 760937-92-6. Pack Sizes: 250 mg. Product ID: B0084-461910. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Teneligliptin HBr | Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro. Group: Pharmaceutical. CAS No. 906093-29-6. Pack Sizes: 250 mg. Product ID: B0084-463677. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin | Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from there use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. CAS No. 274901-16-5. Pack Sizes: 5 g. Product ID: NP3358. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurities | Vildagliptin Impurities are critical in the pharmaceutical sector for assessing the purity of Vildagliptin, a medication widely used to manage type 2 diabetes by inhibiting dipeptidyl peptidase-4 (DPP-4). These impurities serve as benchmarks to ensure drug safety and efficacy during formulation and quality control processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity 3 Trifluoroacetate | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 565453-41-0. Pack Sizes: 10 mg. Product ID: B2694-485165. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity A | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 565453-39-6. Pack Sizes: 250 mg. Product ID: B2694-284718. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity B | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1036959-23-5. Pack Sizes: 500 mg. Product ID: B2694-485168. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Impurity E hydrochloride | An impurity of Vildagliptin, an anti-hyperglycemic agent of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Group: Pharmaceutical. Pack Sizes: 25 mg. Product ID: B2694-074944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vildagliptin Related Compound A | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 741657-02-3. Pack Sizes: 10 mg. Product ID: B2694-290136. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
